{"id":"W3031689252","doi":"10.1200/jco.2020.38.15_suppl.tps6107","title":"ENGOT-EN6/NSGO-RUBY: A phase III, randomized, double-blind, multicenter study of dostarlimab + carboplatin-paclitaxel versus placebo + carboplatin-paclitaxel in recurrent or primary advanced endometrial cancer (EC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"GlaxoSmithKline","keywords":"Carboplatin; Medicine; Paclitaxel; Clinical endpoint; Internal medicine; Placebo; Radiation therapy; Oncology; Endometrial cancer; Surgery; Chemotherapy; Clinical trial; Cancer; Cisplatin; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002753737,0.002242263,0.002496521,0.0005604004,0.000471017,0.000974061,0.001264353,0.00189868,0.007624056],"category_scores_gemma":[0.001500601,0.0007722221,0.001414882,0.0004186815,0.001433451,0.001013446,0.0004948046,0.002911519,0.001368507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006292313,"about_ca_system_score_gemma":0.00169274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001078503,"about_ca_topic_score_gemma":0.002954079,"domain_scores_codex":[0.9993103,0.0004340498,0.00002803847,0.00008152725,0.00004971015,0.00009652964],"domain_scores_gemma":[0.9991944,0.0001770022,0.0001667138,0.00005697821,0.00005360976,0.0003511952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9682938,0.01432862,0.0004991262,0.0005747374,0.0004028847,0.00003057559,0.00004836574,0.0003117601,0.00364394,0.0001090321,0.0007055485,0.01105165],"study_design_scores_gemma":[0.9330135,0.06510969,0.0007207011,0.00001525334,0.0001525457,0.0000200277,0.00001256595,0.0001975722,0.0003176232,0.00005369707,0.000379925,0.00000669957],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9783168,0.004076527,0.000897165,0.000734147,0.0004517015,0.01083954,0.001797804,0.0002509592,0.002635377],"genre_scores_gemma":[0.9617596,0.004089074,0.004837114,0.002128341,0.0004531656,0.01522423,0.002947399,0.00007088729,0.008490088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007624056,"threshold_uncertainty_score":0.02550501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2371395096343411,"score_gpt":0.5052744386797309,"score_spread":0.2681349290453897,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}